Used in pharmaceutical research as a potent and selective agonist for adenosine receptors, particularly targeting the A3 adenosine receptor subtype. It shows promise in the development of therapies for inflammatory conditions, ischemic injury, and certain types of cancer due to its ability to modulate cell signaling pathways involved in cell survival and immune response. Its structural configuration enhances metabolic stability and receptor binding affinity, making it a valuable lead compound in drug design. Investigated for potential use in ophthalmic treatments and cardioprotective agents due to its tissue-specific effects and ability to reduce inflammation and apoptosis in preclinical models.